Overview
Xiaofan Yu practices practicing medicine in Beijing, China.
Yu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Moyamoya Disease, Chronic Subdural Hematoma, Subdural Hematoma, and Stroke.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaofan Yu
Is Xiaofan Yu a top-rated expert for Moyamoya Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaofan Yu is classified as an Distinguished expert for Moyamoya Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaofan Yu participate in research or clinical trials?
Yes. Xiaofan Yu has published 33 articles and abstracts on conditions like Moyamoya Disease. You can view a list of Xiaofan Yu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Moyamoya DiseaseYu isDistinguished. Learn about Moyamoya Disease.
- Advanced
- Chronic Subdural Hematoma
- Subdural HematomaYu isAdvanced. Learn about Subdural Hematoma.
- Experienced
- StrokeYu isExperienced. Learn about Stroke.